Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Meso Scale Discovery UPLEX NHP FLT3L ASY384well
SDP

Catalog No. 5000079239
Encompass

The Meso Scale Discovery U-PLEX NHP FLT3L 384-Well Assay Kit is a multiplex immunoassay that measures human FLT3 ligand in serum plasma and cell culture supernatants It uses electrochemiluminescence detection technology and provides high sensitivity broad dynamic range and intra- and inter-assay precision The kit includes a 384-well plate coated with capture antibodies detection antibodies labeled with MSD SULFO-TAG calibrators and controls It allows efficient and accurate quantification of FLT3 ligand from small sample volumes The kit has high lot-to-lot consistency and is suitable for biomarker research and drug discovery applications

Catalog No. 50-000-79239 Supplier Meso Scale Discovery Supplier No. K256XFK4
May include imposed supplier surcharges.
Add to Cart
Add to Cart
Request a Quote

missing translation for 'validMainframeMsg'

The Meso Scale Discovery U-PLEX NHP FLT3L 384-Well Assay Kit is a multiplex immunoassay that measures human FLT3 ligand in serum plasma and cell culture supernatants It uses electrochemiluminescence detection technology and provides high sensitivity broad dynamic range and intra- and inter-assay precision The kit includes a 384-well plate coated with capture antibodies detection antibodies labeled with MSD SULFO-TAG calibrators and controls It allows efficient and accurate quantification of FLT3 ligand from small sample volumes The kit has high lot-to-lot consistency and is suitable for biomarker research and drug discovery applications

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.